Abstract
The condensed version: Thiolated glycol chitosan can form stable nanoparticles with polymerized siRNAs through charge-charge interactions and self-cross-linking (see scheme). This poly-siRNA/glycol chitosan nanoparticles (psi-TGC) provided sufficient in vivo stability for systemic delivery of siRNAs. Knockdown of tumor proteins by psi-TGC resulted in a reduction in tumor size and vascularization.
| Original language | English |
|---|---|
| Pages (from-to) | 7203-7207 |
| Number of pages | 5 |
| Journal | Angewandte Chemie - International Edition |
| Volume | 51 |
| Issue number | 29 |
| DOIs | |
| State | Published - 16 Jul 2012 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antitumor agents
- Glycol chitosan
- Nanoparticles
- Poly-siRNA
- SiRNA delivery
Fingerprint
Dive into the research topics of 'Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver